FORMULATION AND EVALUATION OF INVASOMAL AND ETHOSOMAL GEL FOR CURCUMIN AND DETERMINATION OF ANTI- FUNGAL ACTIVITY

Q3 Materials Science
A. Krishna sailaja, Thoudaboina Meghana
{"title":"FORMULATION AND EVALUATION OF INVASOMAL AND ETHOSOMAL GEL FOR CURCUMIN AND DETERMINATION OF ANTI- FUNGAL ACTIVITY","authors":"A. Krishna sailaja, Thoudaboina Meghana","doi":"10.2174/2405461508666230329122937","DOIUrl":null,"url":null,"abstract":"\n\nDespite exhibiting anti-inflammatory, antiseptic, and anti-cancer properties, curcumin is not exhibiting the same efficacy as that other non-steroidal anti-inflammatory agents and anti-cancer drugs. The main reason is its poor solubility and poor permeability. To improve the solubility the particle size has to be reduced to the nano level and to improve the permeability vesicular drug delivery approaches have to be adapted. By developing invasomal and ethosomal gels the bioavailability of curcumin can be enhanced\n\n\n\nThe main aim of the study is to develop Invasomal and Ethosomal drug delivery systems for curcumin by various techniques\n\n\n\nCurcumin loaded invasomes were prepared by using a thin film hydration method. Six formulations were prepared by varying drug to lipid ratios (INV1 to INV6). Soya lecithin was used as a phospholipid, span60 was used as a surfactant, limonene was used as terpene, ethanol and chloroform were used as solvents. Curcumin-loaded ethosomes were prepared by using a hot method. Five formulations were prepared by increasing lipid concentration (E1 to E5). Soya lecithin as lipid, propylene glycol, and ethanol as solvent. The prepared formulations were evaluated for particle size, zeta potential, drug content, entrapment efficiency. and in vitro drug release studies\n\n\n\nAmong all the formulations of Invasomes, INV3 formulation containing a 1:5 ratio of the drug (40mg) to lipid (200mg) was considered as best formulation because of its particle size of 327. A total of 1nm, zeta potential of -32.6mV, highest drug content of 97.5%, entrapment efficiency of 96%, and in vitro drug release of 95% in a time period of 12hrs. Among all the formulations of ethosomes, the E3 formulation was considered as best formulation due to its particle size of 697.5 nm, zeta potential of -28.0Mv, highest drug content of 97.3%, entrapment efficiency of 90%, and in vitro drug release of 94.6% in a time period of 12hrs.\n\n\n\nThe best invasomal and ethosomal formulations were incorporated into gel and evaluated for pH, viscosity, Spreadability, drug content, in vitro drug release studies, and ex vivo studies. INV3 and E3 were incorporated into gel and comparative studies were made with plain gel. Among the three gels (PG, INV3G, E3G), invasomal gel (INV3) exhibited the highest \ncontent drug content of 81%, pH of 6.6, spreadability 14.8g cm/sec, invitro drug release of 90.6%, ,and ex vivo drug release of 97% in a time period of 12hrs with the release rate of 32.53 microgram/cm2/hr-1/2, the flux of 0.346µg/cm2/hr and permeation coefficient of 42.71cm/hr\n","PeriodicalId":10924,"journal":{"name":"Current Nanomaterials","volume":" ","pages":""},"PeriodicalIF":0.0000,"publicationDate":"2023-03-29","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Current Nanomaterials","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.2174/2405461508666230329122937","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q3","JCRName":"Materials Science","Score":null,"Total":0}
引用次数: 0

Abstract

Despite exhibiting anti-inflammatory, antiseptic, and anti-cancer properties, curcumin is not exhibiting the same efficacy as that other non-steroidal anti-inflammatory agents and anti-cancer drugs. The main reason is its poor solubility and poor permeability. To improve the solubility the particle size has to be reduced to the nano level and to improve the permeability vesicular drug delivery approaches have to be adapted. By developing invasomal and ethosomal gels the bioavailability of curcumin can be enhanced The main aim of the study is to develop Invasomal and Ethosomal drug delivery systems for curcumin by various techniques Curcumin loaded invasomes were prepared by using a thin film hydration method. Six formulations were prepared by varying drug to lipid ratios (INV1 to INV6). Soya lecithin was used as a phospholipid, span60 was used as a surfactant, limonene was used as terpene, ethanol and chloroform were used as solvents. Curcumin-loaded ethosomes were prepared by using a hot method. Five formulations were prepared by increasing lipid concentration (E1 to E5). Soya lecithin as lipid, propylene glycol, and ethanol as solvent. The prepared formulations were evaluated for particle size, zeta potential, drug content, entrapment efficiency. and in vitro drug release studies Among all the formulations of Invasomes, INV3 formulation containing a 1:5 ratio of the drug (40mg) to lipid (200mg) was considered as best formulation because of its particle size of 327. A total of 1nm, zeta potential of -32.6mV, highest drug content of 97.5%, entrapment efficiency of 96%, and in vitro drug release of 95% in a time period of 12hrs. Among all the formulations of ethosomes, the E3 formulation was considered as best formulation due to its particle size of 697.5 nm, zeta potential of -28.0Mv, highest drug content of 97.3%, entrapment efficiency of 90%, and in vitro drug release of 94.6% in a time period of 12hrs. The best invasomal and ethosomal formulations were incorporated into gel and evaluated for pH, viscosity, Spreadability, drug content, in vitro drug release studies, and ex vivo studies. INV3 and E3 were incorporated into gel and comparative studies were made with plain gel. Among the three gels (PG, INV3G, E3G), invasomal gel (INV3) exhibited the highest content drug content of 81%, pH of 6.6, spreadability 14.8g cm/sec, invitro drug release of 90.6%, ,and ex vivo drug release of 97% in a time period of 12hrs with the release rate of 32.53 microgram/cm2/hr-1/2, the flux of 0.346µg/cm2/hr and permeation coefficient of 42.71cm/hr
姜黄素侵入体和溶体凝胶的制备、评价及抗真菌活性测定
尽管姜黄素具有抗炎、抗菌和抗癌的特性,但其功效却不如其他非甾体类抗炎剂和抗癌药物。主要原因是其溶解度差,渗透性差。为了提高溶解度,必须将颗粒尺寸减小到纳米级,并提高渗透性,必须采用囊泡给药方法。本研究的主要目的是利用各种技术,开发姜黄素的侵入体和体质体给药系统。采用薄膜水合法制备了姜黄素负载的侵入体。通过不同的药脂比(INV1到INV6)制备了6种制剂。以大豆卵磷脂为磷脂,span60为表面活性剂,柠檬烯为萜烯,乙醇和氯仿为溶剂。采用热法制备了姜黄素负载体。通过增加脂质浓度(E1 ~ E5)制备5种配方。大豆卵磷脂为脂质,丙二醇和乙醇为溶剂。对制备的制剂进行粒径、zeta电位、药物含量、包封效率等评价。在Invasomes的所有制剂中,INV3的粒径为327,其药物(40mg)与脂质(200mg)的比例为1:5,被认为是最佳制剂。共1nm, zeta电位为-32.6mV,最高药物含量为97.5%,包封效率为96%,在12hrs的时间内体外释药率为95%。在所有制剂中,E3制剂因其粒径为697.5 nm, zeta电位为-28.0Mv,最高药物含量为97.3%,包封效率为90%,体外12hrs释药率为94.6%而被认为是最佳制剂。将最佳的侵入体和溶体制剂掺入凝胶中,并对pH、粘度、铺展性、药物含量、体外药物释放研究和离体研究进行评估。将INV3和E3加入凝胶中,与普通凝胶进行对比研究。3种凝胶(PG、INV3G、E3G)中,INV3在12hrs时间内的药物含量最高,为81%,pH为6.6,扩散率为14.8g cm/sec,体外释药率为90.6%,体外释药率为97%,释药率为32.53微克/cm2/hr-1/2,通量为0.346µg/cm2/hr,渗透系数为42.71cm/hr
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 求助全文
来源期刊
Current Nanomaterials
Current Nanomaterials Materials Science-Materials Science (miscellaneous)
CiteScore
1.60
自引率
0.00%
发文量
53
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术官方微信